Lanadelumab-FLYO - Save Up to 90% with Coupons, Discounts & Assistance Programs

Lanadelumab-FLYO is available as one of the following:

• 150 mg/1 mL (150 mg/mL) solution in a single-dose prefilled syringe
  300 mg/2 mL (150 mg/mL) solution in a single-dose prefilled syringe
  300 mg/2 mL (150 mg/mL) solution in a single-dose vial

Lanadelumab-FLYO is a plasma kallikrein inhibitor and is used to prevent HAE attacks in people 12 years and older.

Lanadelumab-FLYO is a monoclonal antibody that’s in a group of medications called plasma kallikrein inhibitors. It blocks the activity of a protein in your blood called plasma kallikrein. Plasma kallikrein is more active in people with hereditary angioedema (HAE) and raises the production of bradykinin, a substance that’s responsible for pain and swelling. By lowering plasma kallikrein activity, Lanadelumab-FLYO can help prevent pain and swelling attacks in people with HAE.

Lanadelumab-FLYO is typically started at 300 mg injected under the skin every 2 or 4 weeks.

Lanadelumab-FLYO is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you.

Common side effects of Lanadelumab-FLYO:

• Injection site reactions
• Upper respiratory infection
• Headache
• Rash
• Dizziness
• Muscle pain
• Diarrhea

Serious side effects are rare with Lanadelumab-FLYO. Contact your healthcare provider immediately if you experience any of the following.

• Severe allergic reaction: hives, chest tightness, difficulty breathing, wheezing, fast heartbeat, swelling of the tongue or throat

No drug-drug interaction studies have been conducted with Lanadelumab-FLYO. However, always let your physician and pharmacist know about any other medications or supplements (including prescribed and over-the-counter medications, vitamins, and dietary or herbal supplements) that you are currently taking.

Various FDA-approved generic manufacturers

It is not known if Lanadelumab-FLYO can harm your unborn baby. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

• Takhzyro